| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2090950 | CEACAM21 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 19 | - |
PV=0.253 FDR=1 FC=0.063 |
|
| 2090951 | CEACAM21 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 19 | - |
PV=0.122 FDR=1 FC=-0.102 |
|
| 2090952 | RUFY4 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 2 | - |
PV=1 FDR=1 FC=0.169 |
|
| 2090953 | MRRF | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 9 | - |
PV=1 FDR=1 FC=-0.018 |
